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Psoriasis is one of a number of autoimmune diseases 
that display significant HLA associations. In particu­
lar, individuals with onset of disease prior to 40 years of 
age display striking associations with HLA-Cw6 and 
are much more likely to have a positive family for 
psoriasis. However, only about 10% of CW6-positive 
individuals develop disease, suggesting that other ge­
netic and/or environmental factors must be involved. 
Several compelling lines of epidemiologic evidence 
indicate that psoriasis susceptibility is inherited, albeit 
not in a simple monogenic fashion, and that genetic, 
rather than environmental, factors are primarily re­
sponsible for the variability in inheritance of psoriasis. 
Taken together, these observations suggest that one or 
more loci in addition to HLA are necessary for the 
P soriasis affects over four million Americans (about 2%) at an estimated annual cost of $1.6 billion per year [1]. Most of the 150,000 new U.S. cases diagnosed annually occur in individuals less than 30 years of age, and 10,000 of these cases are less than 10 years old at diagnosis [1]. 
At present, the cause of psoriasis is unknown, no curative therapy is 
available, and all effective antipsoriatic treatments can produce sig­
nificant side effects. Therefore, an improved understanding of the 
etiology of psoriasis would be of major benefit for the rational 
design of new antipsoriatic drugs . In this article, we will review the 
available data pertinent to the genetic etiology of psoriasis, and 
explore the implications of this information for the feasibility of 
identifying psoriasis susceptibility genes through a genetic linkage/ 
positional cloning strategy. This subject has also been recently re­
viewed elsewhere by ourselves [4,4a] and others [4b]. 
EPIDEMIOLOGY 
Two large-scale true epidemiologic studies of psoriasis have been 
undertaken, one by Lomholt in the Faroe Islands [2], and one by 
Hellgren in Sweden [3]. Both of these studies revealed significantly 
higher incidence of psoriasis in relatives compared to the general 
population or to the families of spouses, providing strong evidence 
for the genetic basis of this disease (reviewed in [4]). In a popula­
tion-based study based on examination of psoriatic twins identified 
through the Danish Twin Registry, Brandrup and colleagues found 
that 63% (18 of32) of monozygotic (MZ) probands had a psoriatic 
twin [5], yielding a heritability of 91 % according to the method of 
Smith [6] .  A very similar estimate of heritability (91 %) was deter­
mined on the basis of re-analysis of Lomholt's epidemiologic study 
of psoriasis in the Faroe Islands [7]. Brandrup and colleagues con­
cluded that [5] 
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development of psoriasis. The number of additional 
loci is likely to be small, because i) the disease is very 
common il) substantial excess risk of psoriasis is ob­
served in first degree relatives, and iii) nevoid variants 
of psoriasis have been reported, suggestive of somatic 
mutation of a single gene during development. The 
substantial homogeneity of the psoriatic phenotype 
and the clear evidence for increased HLA association 
and heritability in juvenile onset disease indicate that 
despite its complexity, psoriasis is a common disease 
whose etiology is amenable to elucidation through the 
techniques of modern molecular genetics. Key words: 
human genome/gene mapping/autoimmune diseases/epi­
demiology.] Invest DermatoI103:1S0S-1S3S, 1994 
"the variation observed between individuals with respect to 
presence or absence of psoriasis is due almost entirely to their 
gene differences and only to a limited extent to differences 
in the environment which they experience at home or at 
work." 
A lower estimate of heritability was obtained by Watson and col­
leagues [8]. However, the Danish study appears to be more reliable 
as the age of the twin studied was greater, allowing for increased 
penetrance of disease with age. Recently, a study of psoriasis in 
Australian identical twins revealed a heritability of approximately 
80%, although the concordance rate in identical twins was lower 
than that reported in previous studies [9]. 
A number of other epidemiologic studies of psoriasis have been 
conducted on clinic or hospital-based populations; however, many 
of these lacked the matched controls necessary for case-control epi­
demiologic studies. Despite their shortcomings, these studies have 
provided several insights into the genetic nature of psoriasis. Many 
of these studies are referenced in Farber, Nall, and Watson's retro­
spective study of psoriasis in identical twins [10]. 
There have been many reports of families in which psoriasis is 
common [11]. In virtually all kindreds reported to date, the mode of 
inheritance has been reported as consistent with autosomal domi­
nant with reduced penetrance vs. polygenic inheritance, with an 
equal sex ratio [11]. One of these kindreds, reported by Abele et al l12], contained 815 members, of whom 537 were in direct genetic 
ine. In this kindred, of the 402 individuals examined, 44 were 
affec�ed. Although the pattern of inheritance in this family was 
inferred to be simple autosomal dominant with reduced penetrance 
(60%, other studies measuring the frequency of psoriasis in sibships 
with 0, 1, or 2 affected parents does not fit either a simple autosomal 
dominant or recessive model, even after accounting for age-depen­
den�penetrance [8,13]. The presence of psoriasis in children of two 
unaffected parents is particularly difficult to reconcile with an auto-
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Figure 1. Venn diagram depicting the relationship of HLA-Cw6, 
HLA-DR7, and psoriasis in the general population. The areas of the 
shaded circles and their intersections are approximately proportional to that 
fraction of the total population affected by any single or combination of 
phenotypic traits shown. 
somal dominant, single-gene model. The alternative explanation 
for these data is that psoriasis is determined by more than one factor, 
which could be environmental, genetic, or both. The former con­
cept is termed polygenic, and the latter, multifactorial inheritance. 
Although the identical twin data discussed earlier provides strong 
evidence for the heritability of psoriasis, it is important to remember 
that identical twins have been discordant for psoriasis in some 30 to 
70% of cases [5,9,10]. Although this could be explained by somatic 
mutation during development of the T-cell and/or B-cell reper­
toires, it is also possible that differences in environmental exposure 
are responsible (ie, infections, stress, trauma, climate, etc.). Given 
the prominent evidence for immune system involvement in psoria­
sis, it is not surprising that environmental factors may play a signifi­
cant role. However, to focus entirely on the environmental aspect of 
psoriasis etiology would overlook a genetic component that is 
among the strongest of all the so-called autoimmune diseases, 
whether primarily manifested in the skin or in other organ systems 
(reviewed in [4]). 
HLA ASSOCIATIONS 
Psoriasis belongs to a group of immunopathologic diseases that 
show significant HLA associations, including insulin-dependent 
diabetes mellitus, rheumatoid arthritis, multiple sclerosis, thyroidi­
tis, Sjogren's syndrome, celiac disease/dermatitis herpetiformis, 
pemphigus vulgaris, and the spondyloarthropathies, among others. 
Many of these diseases are quite common (relative to most mono­
genic disorders), and display a complex pattern of inheritance in 
which only a limited number of individuals in the population carry­
ing the susceptibility allele actually develops disease. This relation­
ship is outlined for psoriasis in Fig 1. Evidence for the involvement 
of specific environmental factors (e.g., antigens) exists in several of 
these conditions, Reiter's syndrome and dermatitis herpetiformis 
(DH) being two examples that display prominent dermatologic 
manifestations [14,15]. However, in each condition, disease occurs 
in only a fraction of those individuals carrying the implicated HLA 
susceptibility allele and exposed to the offending environmental 
factor, strongly suggesting the participation of additional genes 
and/or environmental factors [15-18]. 
Numerous studies attest to the involvement of specific HLA al-
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Ieles in psoriasis [19 -25]. The serologically-defined class I antigens 
HLA-BI3,BI7,B39,B57, Cw6, and Cw7, and the class II antigens 
HLA-DR4 and DR7 all show increased association with psoriasis in 
population studies. Of these, the greatest relative risk has been asso­
ciated with HLA-Cw6 [22]t; however, the percentages of psoriatics 
positive for HLA-DR7 and HLA-Cw6 are nearly the same (each 
about 70%, [25]). The difference in relative risk is accounted for by 
the higher frequency ofHLA-DR7 in the general population (about 
25%) relative to HLA-Cw6 (about 10%) (Fig 1). This figure also 
reflects the fact that these two alleles are frequently inherited as a 
haplotype (that is, on the same parental chromosome). As a conse­
quence, it remains unclear whether it is HLA-Cw6, HLA-DR7, or 
an allele at some other HLA or nearby non-HLA locus that is the 
major HLA-linked determinant of psoriasis susceptibility. 
JUVENILE ONSET PSORIASIS 
The peak age of onset of psoriasis is between 15 and 25 years, and 
two-thirds to three-fourths of patients experience onset before the 
age of 40 [25-27]. Henseler and Christophers have used the age of 
onset and HLA typing data to define two types of psoriasis [25,26]. 
Type I psoriatics (HLA-Cw6-positive, age of onset < 40 years) are 
much more likely than type II patients (HLA-Cw6-negative, age of 
onset> 40 years) to have affected parents (44% versus 0%) and to 
experience severe and recurrent disease (75% versus 25%) [25,26]. 
These results suggest that it is reasonable to select probands for 
juvenile onset disease to identify kindreds in which segregation of 
psoriasis may be detected. 
HOW MANY GENES? 
If psoriasis is to be amenable to the techniques of modern molecular 
genetics, especially the so-called parametric or LOD score methods 
of analysis, it is important that the number of major genes that 
predispose to disease be limited. There are three lines of evidence 
that suggest that this is likely to be the case. The first is that psoriasis 
is a very common disease, reaching a frequency of 1 to 3% in the 
Northern European and U.S. populations. If psoriasis were deter­
mined by multiple, unlinked genes, each of them would have to be 
present at high frequency in the population to account for the fre­
quency of the disease. For instance, if 5 independently-segregating, 
completely penetrant genes of equal predisposing power and equal 
frequency, f, were required, and the population frequency of psoria­
sis is 2%, then under an autosomal dominant model for each gene 
(f)s = 0.02, f = 0.46. In other words, each predisposing gene 
would need to be present in 50% of the population. Such a multi­
gene model would seem a better fit for an uncommon, HLA-asso­
ciated disease such as dermatitis herpetiforrnis, in which the HLA 
association with DQw2 is virtually complete and yet only a very 
small fraction (less than 0.03%) ofHLA-DQw2-positive individu­
als go on to develop disease [17 -19]. In contrast, in psoriasis nearly 
10% of HLA-Cw6-positive individuals develop psoriasis (Fig 1), 
suggestive of the involvement of only a limited number of indepen­
dent genetic factors. 
The second reason that the number of genes involved is likely to 
be limited is the relative risk of developing psoriasis in first-degree 
relatives of psoriatics. Thus, Hellgren's Swedish study [22] found 
the frequency of psoriasis to be 7.80/0 in first-degree relatives, and 
2.99% in second-degree relatives, compared to 3.14% of age-, sex-, 
occupation-, and geographically matched relatives of normal con­
trols, and to an overall prevalence of 1.97% in the population exam­
ined. Our re-analysis of these data revealed that the odds ratio for 
developing psoriasis in first-degree relatives was 2.72 (95% confi­
dence interval = 1.53-4.83). If many independent, unlinked genes 
were all required, the probability of inheriting them all would de­
crease by (1/2)D, where n is the number of unlinked genes involved, 
and a relative risk of this magnitude in first degree relatives would 
t LinJD, Auerbach AD, Auerbach a, Allen RG, Mann WR, Olsen DA, 
Gottlieb AB, Carter DM: Genetic linkage studies in psoriasis (abstt).J Invest 
Dermato/96:535A, 1991. 
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be unlikely. However, these considerations do not rule out the 
possibility of additive or incremental effects of many different 
genes. 
Nevoid psoriasis is an unusual clinical observation that further 
suggests that only a limited number of genes determine psoriasis. 
Atherton, Kahana, and Russell-Jones have described a unilateral 
eruption, distributed along the lines of Blaschko in a two-year-old 
child, which was histologically indistinguishable from psoriasis, 
improved by sunlight and anthralin therapy, and worsened after 
upper respiratory infections [28]. They speculated that the child was 
a mosaic for the genetic abnormality present throughout the skin of 
an ordinary psoriatic. Given the correctness of the clinical and his­
tologic diagnosis, it is difficult to imagine how independent muta­
tions in multiple, unlinked psoriasis genes could arise during devel­
opment to produce such a mosaic. The existence of nevoid psoriasis 
also points out that at least one of the genes involved in psoriasis 
must be expressed in the skin itself, rather than in circulating cells of 
the immune system, because the latter would not be predicted to 
produce localized involvement. 
PSORIASIS MOLECULAR GENETICS 
Despite the complexities of psoriasis inheritance outlined above, the 
recent identification of genes responsible for other diseases such as 
cystic fibrosis, neurofibromatosis, fragile X syndrome, and Du­
chenne's muscular dystrophy demonstrate that the methods are at 
hand for genetic identification of loci that contribute to psoriasis 
susceptibility [29,30]. That the HLA region is one such locus is 
essentially a foregone conclusion, based on the well-established dis­
ease associations reviewed above. Moreover, linkage anaylsis can do 
relatively little to refine the location of a disease predisposition gene 
in a region as small as HLA (approximately three megabases). This 
technique, as well as related techniques such as sib pair and affected 
pedigree member (APM) analysis, are likely to have their greatest 
impact in identifying additional, non-HLA-linked loci. As re­
viewed above, the available data strongly suggest that only a limited 
number of major genes in additional to HLA are likely to be in­
volved in determining susceptibility to psoriasis. Therefore it seems 
reasonable to attempt to identify these genes by genetic methods. 
To date, very little has been published evaluating psoriasis sus­
ceptibility on the basis of linkage specific genes [21,24,31], and thus 
far, all studies have focused on HLA. In none of these studies was it 
possible to convincingly demonstrate linkage of psoriasis to the 
HLA locus despite the unambiguous evidence ofHLA associations. 
In collaboration with Drs. Tilo Henseler, Enno Christophers, Ste­
fan J enisch, and Eckhard Westphal in Kiel, Germany, we have been 
identifying, clinically evaluating, HLA typing, and immortalizing 
lymphocytes from affected and unaffected members of multiplex 
psoriasis kindreds identified in Michigan and in northern Germany. 
Probands have been identified in our clinic populations on the basis 
of juvenile onset. The minimum criteria for inclusion in the study 
are 1) three generations available for analysis, 2) at least three af­
fected first-degree relatives, and 3) either a history of psoriasis in at 
least two of these generations or at least three affected siblings in a 
single generation. Kindreds collected thus far resemble those previ­
ously reported in that apparent autosomal dominance with reduced 
penetrance is observed. Based on LOD score analysis of these 
kindreds using four chromosome 6p markers, we have reached con­
clusions similar to those of previous authors regarding the lack of 
tight linkage to the HLA region (unpublished data). However, the 
assumptions that have been used in these analyses may be overly 
simplistic, as they involve monogenic autosomal dominance, the 
absence of sporadic cases, linear, age-dependent penetrance. and the 
absence of imprinting. 
Sib pair and affected pedigree member methods offer substantial 
advantages over linkage-analysis methods, in that no assumptions 
regarding the model of disease inherited, penetrance. sporadic cases, 
or other factors are required. [32]. Once such sib-pair analysis of 
psoriasis was recently published by Suarez-Almazor and Russell 
l33]. These authors found two identical HLAhaplotypes in 13 of15 
affected sib pairs. Although it was not clear whether the sib pairs in 
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this study were truly identical by descent, rather than identical by 
state, the results were interpreted by the authors to suggest that 
more than one HLA linked gene may contribute to psoriasis [33]. 
Although the interpretation of these results is not as yet clear, the 
excess of individuals identical by descent for two HLA alleles sug­
gests that either more than one HLA-linked gene is required, or that 
a gene dosage effect involving alleles at one or more loci is present. 
In collaboration with the University ofKiel, we have performed 
HLA class I and class II typing on many of the individuals in our 
psoriasis kindreds. Thus far, this anaylsis has revealed several exam­
ples of inheritance of HLA Cw6 from an unaffected parent with no 
family history of psoriasis (unpublished data). These results confirm 
those of two previous investigations [21,24], and strongly suggest 
that the presence of the HLA Cw6 allele is a necessary but not 
sufficient condition for development of psoriasis. 
FUTURE DIRECTIONS 
At present, we are completing the collection of our kindreds, and 
plan to make use of additional kindreds currently being collected by 
the National Psoriasis Foundation Psoriasis Tissue Bank as they 
become available. Future studies in our laboratory will be directed 
toward scanning the genome for additional, non - HLA-linked sus­
ceptibility loci, making use of the rapidly-expanding library of 
mapped microsatellite markers, as well as recently-developed ex­
tensions of sib pair, APM, and LOD score methods for multilocus 
involvement. In addition, the use of DNA-based methods for HLA 
typing will allow further dissection of HLA genes themselves for 
the possible existence of disease epitopes shared between different 
HLA alleles. These studies should eventually provide significant 
clues, and ultimately a molecular understanding of, the etiology as 
well as the pathogenesis of psoriasis. 
Note Added in Proof Evidence for linkage of psoriasis to a locus on 
distal human chromosome 179 in some, but not all, psoriasis fami­
lies has recently been reported [33a]. 
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